[{"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-001", "question": "A 3-week-old infant presents after an apparent life-threatening event with prolonged apnea requiring bag-mask ventilation. Polysomnography demonstrates profound hypoventilation during sleep with PaCO2 >60 mmHg. Genetic testing reveals a heterozygous non-polyalanine repeat expansion mutation in PHOX2B. Which of the following is the most appropriate next step in management?", "options": ["Initiate non-invasive ventilation with backup rate of 12 breaths/min and pressure support of 10 cm H2O", "Perform rectal suction biopsy to evaluate for Hirschsprung disease before initiating ventilation", "Initiate non-invasive ventilation with backup rate >20 breaths/min and avoid all opioid analgesics", "Prescribe supplemental oxygen at 0.5 L/min and schedule genetic counseling", "Admit for 24-hour video EEG to rule out seizure disorder"], "answer": "C", "answer_index": 2, "explanation": "Congenital central hypoventilation syndrome with non-polyalanine PHOX2B mutations requires aggressive ventilatory support with backup rates >20 breaths/min to prevent hypercapnia-induced neuronal injury. These patients have extreme sensitivity to sedatives, particularly opioids, which can precipitate fatal apnea. While Hirschsprung disease is associated with certain PHOX2B mutations, it does not precede the need for immediate ventilatory support. Standard backup rates of 12 are insufficient, and oxygen alone worsens hypoventilation.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: 3-week-old with ALTE requiring ventilation, polysomnography showing sleep hypoventilation with PaCO2 >60 mmHg, and heterozygous non-polyalanine repeat expansion mutation in PHOX2B, pointing to severe congenital central hypoventilation syndrome (CCHS). These clues prioritize immediate aggressive ventilatory support over diagnostics or inadequate interventions.\\nMain logical issue(s), if any: None; stem provides sufficient details for discriminating a single best next step without contradictions or underspecification, as genetic confirmation and clinical findings isolate C as optimal.\\nMain medical accuracy issue(s), if any: None; aligns with ATS guidelines on CCHS management, emphasizing high backup rates (>20/min) for NPARM mutations to prevent hypercapnia, opioid avoidance due to sensitivity, and ventilation priority over Hirschsprung screening. Oxygen alone is insufficient and may mask issues, while standard rates (A) are inadequate for severe cases.\\nMinimal fix: No fix needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: 3-week-old with ALTE requiring ventilation, polysomnography showing sleep hypoventilation with PaCO2 >60 mmHg, and heterozygous non-polyalanine repeat expansion mutation in PHOX2B, pointing to severe congenital central hypoventilation syndrome (CCHS). These clues prioritize immediate aggressive ventilatory support over diagnostics or inadequate interventions.\nMain logical issue(s), if any: None; stem provides sufficient details for discriminating a single best next step without contradictions or underspecification, as genetic confirmation and clinical findings isolate C as optimal.\nMain medical accuracy issue(s), if any: None; aligns with ATS guidelines on CCHS management, emphasizing high backup rates (>20/min) for NPARM mutations to prevent hypercapnia, opioid avoidance due to sensitivity, and ventilation priority over Hirschsprung screening. Oxygen alone is insufficient and may mask issues, while standard rates (A) are inadequate for severe cases.\nMinimal fix: No fix needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-002", "question": "A term neonate develops refractory seizures on day 2 of life. The mother received isoniazid 300 mg daily throughout pregnancy for latent tuberculosis. Standard anticonvulsants have failed to control the seizures. Which of the following is the most appropriate immediate management?", "options": ["Administer pyridoxine 50 mg IV once and continue phenobarbital", "Initiate continuous video-EEG monitoring and administer pyridoxine 100 mg IV every 6 hours", "Perform emergent MRI brain to evaluate for structural lesions", "Administer pyridoxal-5-phosphate 30 mg/kg/day and discontinue all other anticonvulsants", "Obtain lumbar puncture to evaluate for meningitis before initiating specific therapy"], "answer": "B", "answer_index": 1, "explanation": "Isoniazid use during pregnancy causes pyridoxine deficiency in neonates, leading to refractory seizures that respond only to high-dose pyridoxine replacement. The diagnosis requires continuous EEG monitoring to document response to therapy, as clinical improvement may be delayed. A single 50 mg dose is insufficient, and pyridoxal-5-phosphate is the active form but not the standard initial therapy. Delaying specific therapy for imaging or LP risks ongoing seizure-induced brain injury.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Term neonate with refractory seizures on day 2 of life, maternal isoniazid 300 mg daily throughout pregnancy, failure of standard anticonvulsants—these strongly suggest isoniazid-induced pyridoxine deficiency as the cause, driving the need for pyridoxine trial with monitoring. Main logical issue(s): None; the vignette provides sufficient details to discriminate B as the unique best option, with no contradictions or underspecification leading to multiple defensible answers. Alternatives are inferior: A uses insufficient single dose; C prioritizes imaging over targeted therapy; D employs pyridoxal-5-phosphate (better for genetic dependency, not deficiency) and risks by discontinuing anticonvulsants; E delays for LP. Main medical accuracy issue(s): Overall consistent with standards for managing suspected pyridoxine deficiency seizures (e.g., per neonatal epilepsy guidelines, IV pyridoxine trial under EEG is key), but B's regimen of 100 mg IV every 6 hours implies excessive dosing (potentially 133 mg/kg/day for a 3 kg neonate), whereas standard immediate management is a 50-100 mg IV bolus during EEG, with repeats if needed and lower maintenance (5-15 mg/kg/day) if responsive. This represents minor nonstandard nuance without harming core teaching point. Minimal fix: Revise B to 'Initiate continuous video-EEG monitoring and administer pyridoxine 100 mg IV stat'.\",\n  \"medical_accuracy_score\": 3,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Term neonate with refractory seizures on day 2 of life, maternal isoniazid 300 mg daily throughout pregnancy, failure of standard anticonvulsants—these strongly suggest isoniazid-induced pyridoxine deficiency as the cause, driving the need for pyridoxine trial with monitoring. Main logical issue(s): None; the vignette provides sufficient details to discriminate B as the unique best option, with no contradictions or underspecification leading to multiple defensible answers. Alternatives are inferior: A uses insufficient single dose; C prioritizes imaging over targeted therapy; D employs pyridoxal-5-phosphate (better for genetic dependency, not deficiency) and risks by discontinuing anticonvulsants; E delays for LP. Main medical accuracy issue(s): Overall consistent with standards for managing suspected pyridoxine deficiency seizures (e.g., per neonatal epilepsy guidelines, IV pyridoxine trial under EEG is key), but B's regimen of 100 mg IV every 6 hours implies excessive dosing (potentially 133 mg/kg/day for a 3 kg neonate), whereas standard immediate management is a 50-100 mg IV bolus during EEG, with repeats if needed and lower maintenance (5-15 mg/kg/day) if responsive. This represents minor nonstandard nuance without harming core teaching point. Minimal fix: Revise B to 'Initiate continuous video-EEG monitoring and administer pyridoxine 100 mg IV stat'.", "medical_accuracy_score": 3, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-003", "question": "A 4-year-old child with Williams syndrome is scheduled for cardiac catheterization to evaluate supravalvular aortic stenosis. Preoperative echocardiography demonstrates diffuse coronary artery narrowing. The child has a history of hypercalcemia managed with dietary restriction. Which anesthetic agent is most contraindicated in this patient?", "options": ["Sevoflurane due to risk of malignant hyperthermia", "Propofol due to risk of propofol infusion syndrome", "Ketamine due to risk of exacerbating hypercalcemia", "Dexmedetomidine due to risk of severe bradycardia", "Isoflurane due to risk of coronary steal phenomenon"], "answer": "E", "answer_index": 4, "explanation": "Williams syndrome patients with coronary artery stenosis are at high risk for myocardial ischemia. Isoflurane causes coronary vasodilation and can precipitate coronary steal in patients with fixed stenotic lesions, potentially causing fatal arrhythmias. While sevoflurane is generally safe, all volatile anesthetics should be used cautiously. The hypercalcemia in Williams syndrome is not exacerbated by ketamine, and dexmedetomidine-induced bradycardia is manageable. Propofol infusion syndrome is rare with single-bolus dosing.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 4-year-old with Williams syndrome, supravalvular aortic stenosis, diffuse coronary artery narrowing on echo, history of hypercalcemia managed dietarily; question asks for most contraindicated anesthetic agent for cardiac catheterization. These clues highlight risks of myocardial ischemia from coronary stenosis, making agents that could worsen perfusion critical. The stem supports E (isoflurane) as best due to its known coronary vasodilatory effects potentially causing steal phenomenon in fixed stenotic lesions, aligning with Williams syndrome's cardiovascular pathology. Main logical issue(s): None; stem provides sufficient details for discrimination without contradictions or underspecification, allowing unique best answer. Alternatives are inferior: A (sevoflurane) lacks MH association in Williams; B (propofol) PRIS irrelevant for brief use; C (ketamine) does not exacerbate hypercalcemia; D (dexmedetomidine) bradycardia is manageable and not the primary risk here. Main medical accuracy issue(s): None; consistent with standard anesthesiology knowledge on volatile agents in coronary disease— isoflurane has higher steal risk than sevoflurane; hypercalcemia management and other risks accurately represented per guidelines. Minimal fix: None required, as item is unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 4-year-old with Williams syndrome, supravalvular aortic stenosis, diffuse coronary artery narrowing on echo, history of hypercalcemia managed dietarily; question asks for most contraindicated anesthetic agent for cardiac catheterization. These clues highlight risks of myocardial ischemia from coronary stenosis, making agents that could worsen perfusion critical. The stem supports E (isoflurane) as best due to its known coronary vasodilatory effects potentially causing steal phenomenon in fixed stenotic lesions, aligning with Williams syndrome's cardiovascular pathology. Main logical issue(s): None; stem provides sufficient details for discrimination without contradictions or underspecification, allowing unique best answer. Alternatives are inferior: A (sevoflurane) lacks MH association in Williams; B (propofol) PRIS irrelevant for brief use; C (ketamine) does not exacerbate hypercalcemia; D (dexmedetomidine) bradycardia is manageable and not the primary risk here. Main medical accuracy issue(s): None; consistent with standard anesthesiology knowledge on volatile agents in coronary disease— isoflurane has higher steal risk than sevoflurane; hypercalcemia management and other risks accurately represented per guidelines. Minimal fix: None required, as item is unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-004", "question": "A 7-year-old boy with X-linked chronic granulomatous disease presents with persistent fever and right tibial pain despite broad-spectrum antibiotics. MRI demonstrates osteomyelitis. Biopsy cultures grow Aspergillus nidulans. The patient is on prophylactic interferon-gamma 50 mcg/m² three times weekly. Which of the following is the most appropriate management?", "options": ["Increase interferon-gamma to 100 mcg/m² and add voriconazole", "Discontinue interferon-gamma and initiate liposomal amphotericin B alone", "Continue interferon-gamma and initiate voriconazole with therapeutic drug monitoring", "Switch to interferon-alpha and add caspofungin", "Continue current prophylaxis and add oral itraconazole"], "answer": "C", "answer_index": 2, "explanation": "Aspergillus nidulans is uniquely virulent in CGD and requires aggressive antifungal therapy with voriconazole, which has superior activity against this species compared to amphotericin B. Interferon-gamma prophylaxis should be continued as it enhances neutrophil function and improves outcomes. Therapeutic drug monitoring is essential as CGD patients have altered voriconazole metabolism. Interferon-alpha is not used in CGD, and itraconazole has variable absorption and inferior efficacy against A. nidulans.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 7-year-old with X-linked CGD on prophylactic IFN-gamma (50 mcg/m² 3x weekly), persistent fever and tibial pain despite antibiotics, MRI-confirmed osteomyelitis, biopsy growing Aspergillus nidulans. These point to invasive fungal infection in immunocompromised host requiring targeted antifungal while maintaining prophylaxis. The question asks for most appropriate management, implying addition of effective antifungal without disrupting beneficial IFN-gamma. Keyed answer C (continue IFN-gamma and initiate voriconazole with TDM) fits due to voriconazole's superior activity against A. nidulans in CGD, need for TDM in altered metabolism, and evidence supporting continued IFN-gamma for neutrophil enhancement. Alternatives: A requires unsubstantiated dose increase; B wrongly discontinues prophylaxis and uses inferior amphotericin alone; D switches to inappropriate IFN-alpha; E adds suboptimal itraconazole. No main logical issues; stem allows discrimination of single best option without contradictions or underspecification. No main medical accuracy issues; aligns with IDSA guidelines for aspergillosis (voriconazole first-line), CGD management (continue IFN-gamma), and TDM recommendations. Minimal fix: N/A, as item is unambiguous and accurate; optionally, add 'invasive' to specify aspergillosis severity for emphasis.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 7-year-old with X-linked CGD on prophylactic IFN-gamma (50 mcg/m² 3x weekly), persistent fever and tibial pain despite antibiotics, MRI-confirmed osteomyelitis, biopsy growing Aspergillus nidulans. These point to invasive fungal infection in immunocompromised host requiring targeted antifungal while maintaining prophylaxis. The question asks for most appropriate management, implying addition of effective antifungal without disrupting beneficial IFN-gamma. Keyed answer C (continue IFN-gamma and initiate voriconazole with TDM) fits due to voriconazole's superior activity against A. nidulans in CGD, need for TDM in altered metabolism, and evidence supporting continued IFN-gamma for neutrophil enhancement. Alternatives: A requires unsubstantiated dose increase; B wrongly discontinues prophylaxis and uses inferior amphotericin alone; D switches to inappropriate IFN-alpha; E adds suboptimal itraconazole. No main logical issues; stem allows discrimination of single best option without contradictions or underspecification. No main medical accuracy issues; aligns with IDSA guidelines for aspergillosis (voriconazole first-line), CGD management (continue IFN-gamma), and TDM recommendations. Minimal fix: N/A, as item is unambiguous and accurate; optionally, add 'invasive' to specify aspergillosis severity for emphasis.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-005", "question": "A 2-month-old infant presents with delayed separation of the umbilical cord (>3 weeks), severe leukocytosis (WBC 80,000), and recurrent skin infections. Flow cytometry shows absent CD18 expression. Genetic testing confirms ITGB2 mutation. Which of the following is the most appropriate management?", "options": ["Initiate prophylactic antibiotics and schedule stem cell transplant after 1 year of age", "Perform urgent stem cell transplant before onset of severe infections", "Initiate granulocyte colony-stimulating factor and delay transplant until 5 years of age", "Treat infections as they occur and consider transplant only if infections become life-threatening", "Initiate prophylactic interferon-gamma and schedule transplant during adolescence"], "answer": "B", "answer_index": 1, "explanation": "Leukocyte adhesion deficiency type I is a severe immunodeficiency with absent CD18 leading to defective neutrophil adhesion and migration. The prognosis is poor without stem cell transplantation, with most patients dying before age 2 from severe infections. Urgent transplant before the onset of life-threatening infections offers the best survival. Delaying transplant beyond infancy is associated with significantly worse outcomes due to cumulative infectious complications and organ damage. G-CSF and interferon-gamma do not correct the underlying defect.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include the infant's age (2 months), delayed umbilical cord separation (>3 weeks), severe leukocytosis (WBC 80,000), recurrent skin infections, absent CD18 expression, and confirmed ITGB2 mutation, collectively diagnostic of severe leukocyte adhesion deficiency type I (LAD-I), a condition with high mortality from infections without early intervention. These findings imply the need for prompt definitive treatment to prevent life-threatening complications. Main logical issue(s): None; the vignette provides sufficient details to discriminate B as the single best option without contradictions or underspecification. Main medical accuracy issue(s): None; the item's logic aligns with current standards, where hematopoietic stem cell transplantation (HSCT) is the only curative therapy for severe LAD-I, with best outcomes when performed early (ideally before severe infections or organ damage), per guidelines from sources like the Primary Immune Deficiency Treatment Consortium. Prophylactic measures or delays in options A, C, D, and E are inferior as they do not address the underlying defect and risk high mortality (most untreated patients die before age 2). Minimal fix: No fix required; the item is already unambiguous and accurate, though adding 'hematopoietic' to 'stem cell transplant' in options could enhance precision.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include the infant's age (2 months), delayed umbilical cord separation (>3 weeks), severe leukocytosis (WBC 80,000), recurrent skin infections, absent CD18 expression, and confirmed ITGB2 mutation, collectively diagnostic of severe leukocyte adhesion deficiency type I (LAD-I), a condition with high mortality from infections without early intervention. These findings imply the need for prompt definitive treatment to prevent life-threatening complications. Main logical issue(s): None; the vignette provides sufficient details to discriminate B as the single best option without contradictions or underspecification. Main medical accuracy issue(s): None; the item's logic aligns with current standards, where hematopoietic stem cell transplantation (HSCT) is the only curative therapy for severe LAD-I, with best outcomes when performed early (ideally before severe infections or organ damage), per guidelines from sources like the Primary Immune Deficiency Treatment Consortium. Prophylactic measures or delays in options A, C, D, and E are inferior as they do not address the underlying defect and risk high mortality (most untreated patients die before age 2). Minimal fix: No fix required; the item is already unambiguous and accurate, though adding 'hematopoietic' to 'stem cell transplant' in options could enhance precision.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-006", "question": "A 5-year-old boy with King-Denborough syndrome (dysmorphic facies, congenital myopathy, cryptorchidism) is scheduled for inguinal hernia repair. The patient has a known RYR1 mutation. Which of the following is the most appropriate anesthetic plan?", "options": ["Use total intravenous anesthesia with propofol and remifentanil, avoid dantrolene prophylaxis", "Administer dantrolene 2.5 mg/kg IV preoperatively and use sevoflurane", "Use regional anesthesia alone with spinal block, have dantrolene immediately available", "Administer dantrolene 5 mg/kg IV preoperatively and avoid all volatile agents", "Use desflurane with dantrolene 2.5 mg/kg prophylaxis"], "answer": "C", "answer_index": 2, "explanation": "King-Denborough syndrome is associated with malignant hyperthermia susceptibility due to RYR1 mutations. However, prophylactic dantrolene is not recommended due to its own side effects. Regional anesthesia is the preferred technique when feasible, avoiding triggers entirely. If general anesthesia is necessary, total intravenous anesthesia is preferred with dantrolene immediately available, not administered prophylactically. All volatile agents are contraindicated in known MH-susceptible patients.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 5-year-old boy with King-Denborough syndrome, dysmorphic facies, congenital myopathy, cryptorchidism, known RYR1 mutation (indicating malignant hyperthermia susceptibility), scheduled for inguinal hernia repair. These drive the need for an anesthetic plan that avoids MH triggers like volatile anesthetics and succinylcholine, while considering pediatric feasibility. The stem implies a straightforward elective procedure, supporting selection of the safest non-triggering approach. Main logical issue(s): None; the vignette provides sufficient details to discriminate options, with C uniquely best as it avoids general anesthesia triggers entirely via regional technique, aligning with guidelines preferring trigger avoidance when possible. Alternatives are inferior: A requires GA (less ideal), B/E use triggering volatiles, D unnecessarily uses high-dose prophylactic dantrolene. Main medical accuracy issue(s): None; consistent with MHAUS guidelines—prophylactic dantrolene not recommended due to side effects like muscle weakness; regional anesthesia preferred for MH-susceptible patients when feasible; TIVA acceptable if GA needed; volatiles contraindicated. The item's teaching point on MH management is precise and board-relevant. Minimal fix: None required; item is already unambiguous and accurate, though adding 'procedure amenable to regional anesthesia' to stem could enhance clarity without changing intent.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 5-year-old boy with King-Denborough syndrome, dysmorphic facies, congenital myopathy, cryptorchidism, known RYR1 mutation (indicating malignant hyperthermia susceptibility), scheduled for inguinal hernia repair. These drive the need for an anesthetic plan that avoids MH triggers like volatile anesthetics and succinylcholine, while considering pediatric feasibility. The stem implies a straightforward elective procedure, supporting selection of the safest non-triggering approach. Main logical issue(s): None; the vignette provides sufficient details to discriminate options, with C uniquely best as it avoids general anesthesia triggers entirely via regional technique, aligning with guidelines preferring trigger avoidance when possible. Alternatives are inferior: A requires GA (less ideal), B/E use triggering volatiles, D unnecessarily uses high-dose prophylactic dantrolene. Main medical accuracy issue(s): None; consistent with MHAUS guidelines—prophylactic dantrolene not recommended due to side effects like muscle weakness; regional anesthesia preferred for MH-susceptible patients when feasible; TIVA acceptable if GA needed; volatiles contraindicated. The item's teaching point on MH management is precise and board-relevant. Minimal fix: None required; item is already unambiguous and accurate, though adding 'procedure amenable to regional anesthesia' to stem could enhance clarity without changing intent.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-007", "question": "A 32-year-old G2P1 at 34 weeks gestation presents with severe preeclampsia, HELLP syndrome, and acute decompensated peripartum cardiomyopathy (EF 25%). She is started on bromocriptine 2.5 mg twice daily to inhibit lactation. Emergency cesarean delivery is indicated. Which anesthetic technique is most appropriate?", "options": ["General anesthesia with etomidate and low-dose sevoflurane", "Spinal anesthesia with hyperbaric bupivacaine 12 mg", "Epidural anesthesia with slow titration of local anesthetic", "General anesthesia with ketamine and high-dose sevoflurane", "Local infiltration anesthesia with monitored anesthesia care"], "answer": "C", "answer_index": 2, "explanation": "Bromocriptine, a dopamine D2 agonist, can cause severe vasoconstriction and hypertensive crises, particularly when combined with general anesthetic agents. Neuraxial anesthesia (epidural) is preferred in peripartum cardiomyopathy to avoid hemodynamic fluctuations. Slow titration of epidural anesthesia allows for gradual onset and better hemodynamic stability compared to spinal anesthesia, which can cause abrupt sympathectomy and cardiovascular collapse. General anesthesia should be avoided due to the risk of bromocriptine-induced hypertension and myocardial depression.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: M (secondary U). Verdict on keyed answer: Not uniquely determinable. Key stem clues include severe preeclampsia (hypertension risks), HELLP syndrome (implies thrombocytopenia, hemolysis, liver dysfunction), acute decompensated peripartum cardiomyopathy with EF 25% (hemodynamic instability), bromocriptine use (potential vasoconstriction), and emergency cesarean at 34 weeks (need for stable anesthesia). These drive considerations for hemodynamic control and coagulopathy avoidance but fail to specify platelet count or coagulation status, making neuraxial safety unclear. Main logical issue: Underspecified critical detail (e.g., platelet count) requires unstated assumption to identify unique best; if platelets adequate, C (epidural) offers titratable sympathectomy for cardiomyopathy stability; if low (as HELLP suggests), A (GA with etomidate/low sevoflurane) avoids hematoma risk while providing cardiac-stable induction—leading to multiple defensible answers (M). Main medical accuracy issues: Bromocriptine is contraindicated for lactation suppression in postpartum hypertension/preeclampsia due to risks of stroke/MI (FDA warning, outdated practice); rationale overstates specific bromocriptine-GA interaction without evidence; item ignores HELLP-associated thrombocytopenia contraindicating neuraxial anesthesia in many cases, potentially misleading on standard care. Minimal fix: Add 'platelet count 120,000/μL' to stem to confirm neuraxial feasibility, supporting C as unique best while retaining teaching point on titration for stability.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (secondary U). Verdict on keyed answer: Not uniquely determinable. Key stem clues include severe preeclampsia (hypertension risks), HELLP syndrome (implies thrombocytopenia, hemolysis, liver dysfunction), acute decompensated peripartum cardiomyopathy with EF 25% (hemodynamic instability), bromocriptine use (potential vasoconstriction), and emergency cesarean at 34 weeks (need for stable anesthesia). These drive considerations for hemodynamic control and coagulopathy avoidance but fail to specify platelet count or coagulation status, making neuraxial safety unclear. Main logical issue: Underspecified critical detail (e.g., platelet count) requires unstated assumption to identify unique best; if platelets adequate, C (epidural) offers titratable sympathectomy for cardiomyopathy stability; if low (as HELLP suggests), A (GA with etomidate/low sevoflurane) avoids hematoma risk while providing cardiac-stable induction—leading to multiple defensible answers (M). Main medical accuracy issues: Bromocriptine is contraindicated for lactation suppression in postpartum hypertension/preeclampsia due to risks of stroke/MI (FDA warning, outdated practice); rationale overstates specific bromocriptine-GA interaction without evidence; item ignores HELLP-associated thrombocytopenia contraindicating neuraxial anesthesia in many cases, potentially misleading on standard care. Minimal fix: Add 'platelet count 120,000/μL' to stem to confirm neuraxial feasibility, supporting C as unique best while retaining teaching point on titration for stability.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-008", "question": "A 28-year-old Ashkenazi Jewish man develops progressive gait ataxia, dysarthria, and treatment-resistant psychosis with visual hallucinations. Hexosaminidase A activity is 5% of normal. MRI shows cerebellar atrophy. Which of the following is the most appropriate management?", "options": ["Initiate antipsychotic therapy with clozapine and refer for genetic counseling", "Enroll in clinical trial of miglustat substrate reduction therapy", "Initiate intrathecal enzyme replacement therapy with recombinant hexosaminidase A", "Prescribe donepezil for cognitive symptoms and risperidone for psychosis", "Recommend palliative care as no disease-modifying therapy exists"], "answer": "B", "answer_index": 1, "explanation": "Late-onset Tay-Sachs disease (LOTS) is a GM2 gangliosidosis with residual hexosaminidase A activity. While there is no FDA-approved therapy, miglustat has shown promise in clinical trials for substrate reduction. Intrathecal enzyme replacement is experimental and not widely available. Standard antipsychotics treat symptoms but not the underlying disease. Palliative care is premature as disease-modifying trials are ongoing.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: M (secondary U)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues that drive (or fail to drive) a unique best answer: 28-year-old Ashkenazi Jewish man with progressive gait ataxia, dysarthria, treatment-resistant psychosis with visual hallucinations, Hexosaminidase A at 5% normal, and MRI cerebellar atrophy—these strongly indicate late-onset Tay-Sachs disease (LOTS), but do not specify acuity of symptoms or management context (immediate vs. long-term), failing to pinpoint a single best option.\\nMain logical issue(s): Multiple answers defensible (M) as both A (clozapine for resistant psychosis plus genetic counseling) and B (miglustat trial for potential disease modification) are reasonable 'most appropriate management' depending on whether focus is symptomatic relief or experimental therapy; underspecified (U) regarding trial availability, patient eligibility, and symptom severity contributes to this ambiguity.\\nMain medical accuracy issue(s): Mostly accurate depiction of LOTS features and experimental status of miglustat (promising in some GM2 trials but not FDA-approved, with mixed results); however, minor nuance missing—clozapine is standard for resistant psychosis in LOTS, and trials aren't universally accessible; donepezil irrelevant, palliative care not premature with symptomatic options.\\nMinimal fix: Revise stem to add 'After initiating symptomatic therapy for psychosis, the patient's condition continues to worsen. The most appropriate next step in management is...' to prioritize B as unique best.\",\n  \"medical_accuracy_score\": 4,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (secondary U)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues that drive (or fail to drive) a unique best answer: 28-year-old Ashkenazi Jewish man with progressive gait ataxia, dysarthria, treatment-resistant psychosis with visual hallucinations, Hexosaminidase A at 5% normal, and MRI cerebellar atrophy—these strongly indicate late-onset Tay-Sachs disease (LOTS), but do not specify acuity of symptoms or management context (immediate vs. long-term), failing to pinpoint a single best option.\nMain logical issue(s): Multiple answers defensible (M) as both A (clozapine for resistant psychosis plus genetic counseling) and B (miglustat trial for potential disease modification) are reasonable 'most appropriate management' depending on whether focus is symptomatic relief or experimental therapy; underspecified (U) regarding trial availability, patient eligibility, and symptom severity contributes to this ambiguity.\nMain medical accuracy issue(s): Mostly accurate depiction of LOTS features and experimental status of miglustat (promising in some GM2 trials but not FDA-approved, with mixed results); however, minor nuance missing—clozapine is standard for resistant psychosis in LOTS, and trials aren't universally accessible; donepezil irrelevant, palliative care not premature with symptomatic options.\nMinimal fix: Revise stem to add 'After initiating symptomatic therapy for psychosis, the patient's condition continues to worsen. The most appropriate next step in management is...' to prioritize B as unique best.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-009", "question": "A 22-year-old man with schizophrenia has required risperidone 24 mg daily (8 times the standard dose) to achieve therapeutic response. Genetic testing reveals CYP2D6 ultrarapid metabolizer status (gene duplication). Which of the following monitoring parameters is most critical?", "options": ["Weekly complete blood count for agranulocytosis", "Quarterly fasting glucose and lipid panel", "Monthly prolactin level", "Baseline and annual QTc interval monitoring", "Weekly liver function tests"], "answer": "D", "answer_index": 3, "explanation": "CYP2D6 ultrarapid metabolism leads to extremely high doses of risperidone being required, resulting in accumulation of the active metabolite 9-hydroxyrisperidone. This significantly increases the risk of dose-dependent QTc prolongation and torsades de pointes. While metabolic monitoring is important, QTc prolongation is the most immediate life-threatening risk at these supratherapeutic doses. Agranulocytosis is associated with clozapine, not risperidone.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues include a 22-year-old man with schizophrenia requiring risperidone 24 mg daily (8 times standard dose) due to CYP2D6 ultrarapid metabolizer status from gene duplication; these drive the need for monitoring dose-dependent risks like QTc prolongation from active metabolite accumulation. The question asks for the most critical monitoring parameter, implying prioritization of life-threatening risks. Main logical issues: none; the stem provides sufficient details to discriminate D as uniquely best, with alternatives less critical or irrelevant (e.g., A is clozapine-specific). Options allow clear single-best selection without contradictions or underspecification. Main medical accuracy issues: mostly accurate per guidelines; risperidone's QTc risk increases with high doses and metabolite levels in ultrarapid metabolizers, aligning with FDA warnings and APA recommendations for ECG monitoring in at-risk patients. Minor nuance: ultrarapid metabolism accelerates conversion to 9-hydroxyrisperidone, necessitating high doses for efficacy, which can elevate total active moiety and QTc risk, though evidence is not definitive for 'accumulation' phrasing. Other options reflect standard monitoring but not the most immediate threat. Minimal fix: none required; item is unambiguous and accurate as is.\",\n  \"medical_accuracy_score\": 4,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues include a 22-year-old man with schizophrenia requiring risperidone 24 mg daily (8 times standard dose) due to CYP2D6 ultrarapid metabolizer status from gene duplication; these drive the need for monitoring dose-dependent risks like QTc prolongation from active metabolite accumulation. The question asks for the most critical monitoring parameter, implying prioritization of life-threatening risks. Main logical issues: none; the stem provides sufficient details to discriminate D as uniquely best, with alternatives less critical or irrelevant (e.g., A is clozapine-specific). Options allow clear single-best selection without contradictions or underspecification. Main medical accuracy issues: mostly accurate per guidelines; risperidone's QTc risk increases with high doses and metabolite levels in ultrarapid metabolizers, aligning with FDA warnings and APA recommendations for ECG monitoring in at-risk patients. Minor nuance: ultrarapid metabolism accelerates conversion to 9-hydroxyrisperidone, necessitating high doses for efficacy, which can elevate total active moiety and QTc risk, though evidence is not definitive for 'accumulation' phrasing. Other options reflect standard monitoring but not the most immediate threat. Minimal fix: none required; item is unambiguous and accurate as is.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-010", "question": "A 19-year-old woman presents with 2 weeks of progressive psychosis, culminating in nihilistic delusions that she is dead and her organs are rotting (Cotard's syndrome). CSF analysis reveals anti-NMDA receptor antibodies. Which of the following is the most appropriate initial treatment?", "options": ["High-dose oral antipsychotics and psychiatric admission", "Intravenous immunoglobulin 2 g/kg and high-dose corticosteroids", "Electroconvulsive therapy for refractory psychosis", "Plasmapheresis alone", "Rituximab monotherapy"], "answer": "B", "answer_index": 1, "explanation": "NMDA receptor encephalitis is a treatable autoimmune encephalitis that frequently presents with severe psychiatric symptoms including Cotard's syndrome. First-line immunotherapy with IVIG and high-dose corticosteroids is essential and should not be delayed for psychiatric treatment alone. ECT has no role in the acute autoimmune phase. Plasmapheresis alone is less effective than combination therapy, and rituximab is reserved for refractory cases after first-line therapy.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 19-year-old woman with 2 weeks of progressive psychosis including Cotard's syndrome (nihilistic delusions of being dead and organs rotting), and CSF positive for anti-NMDA receptor antibodies, pointing to autoimmune encephalitis requiring prompt immunotherapy over psychiatric management alone. Main logical issue(s), if any: None; the vignette provides sufficient details to discriminate B as the single best initial treatment without contradictions or underspecification, as alternatives are clearly inferior for acute autoimmune etiology. Main medical accuracy issue(s), if any: None; aligns with current guidelines (e.g., Lancet Neurology reviews) for anti-NMDA receptor encephalitis, where first-line therapy is IVIG (2 g/kg) plus high-dose corticosteroids to address autoimmunity, with antipsychotics insufficient alone, ECT not indicated acutely, plasmapheresis better in combination, and rituximab for refractory cases. The rationale correctly emphasizes not delaying immunotherapy. Minimal fix: No edit needed; item is already unambiguous and accurate, but if enhancing, add 'without evidence of underlying tumor' to stem for completeness, though not required here.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 19-year-old woman with 2 weeks of progressive psychosis including Cotard's syndrome (nihilistic delusions of being dead and organs rotting), and CSF positive for anti-NMDA receptor antibodies, pointing to autoimmune encephalitis requiring prompt immunotherapy over psychiatric management alone. Main logical issue(s), if any: None; the vignette provides sufficient details to discriminate B as the single best initial treatment without contradictions or underspecification, as alternatives are clearly inferior for acute autoimmune etiology. Main medical accuracy issue(s), if any: None; aligns with current guidelines (e.g., Lancet Neurology reviews) for anti-NMDA receptor encephalitis, where first-line therapy is IVIG (2 g/kg) plus high-dose corticosteroids to address autoimmunity, with antipsychotics insufficient alone, ECT not indicated acutely, plasmapheresis better in combination, and rituximab for refractory cases. The rationale correctly emphasizes not delaying immunotherapy. Minimal fix: No edit needed; item is already unambiguous and accurate, but if enhancing, add 'without evidence of underlying tumor' to stem for completeness, though not required here.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-011", "question": "A 14-year-old girl with short stature, obesity, and developmental delay presents with seizures. Labs show hypocalcemia (6.8 mg/dL), hyperphosphatemia, and elevated PTH (250 pg/mL). She has brachydactyly and subcutaneous calcifications. Which of the following is the most appropriate diagnostic test?", "options": ["GNAS gene sequencing for activating mutations", "Methylation-specific PCR of the GNAS locus", "Calcium-sensing receptor gene analysis", "Vitamin D 25-hydroxy level", "Thyroid function tests"], "answer": "B", "answer_index": 1, "explanation": "Pseudohypoparathyroidism type 1A is caused by maternally inherited inactivating mutations in GNAS with loss of imprinting. The diagnosis requires methylation-specific PCR to demonstrate abnormal GNAS methylation patterns, which distinguishes it from other forms of PHP and from pseudopseudohypoparathyroidism. Standard gene sequencing alone is insufficient as it doesn't assess imprinting. The biochemical pattern (elevated PTH with hypocalcemia) is characteristic of PTH resistance.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include short stature, obesity, developmental delay, brachydactyly, and subcutaneous calcifications (suggesting Albright hereditary osteodystrophy), plus hypocalcemia, hyperphosphatemia, elevated PTH, and seizures (indicating PTH resistance in pseudohypoparathyroidism type 1A, PHP1A). These findings point to GNAS imprinting defects, making methylation-specific PCR (B) the most appropriate test to confirm abnormal methylation patterns, distinguishing PHP1A from other forms. No main logical issues; the stem provides sufficient discriminating details for a single best answer without contradictions or underspecification. No main medical accuracy issues; the item's logic aligns with current standards for PHP1A diagnosis, emphasizing methylation analysis over standard sequencing due to imprinting involvement, consistent with endocrine guidelines and board-level knowledge. Minimal fix: None needed, as the item is unambiguous and accurate; however, to enhance clarity, option A could specify 'inactivating' instead of 'activating' mutations to better highlight the distractor's error.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include short stature, obesity, developmental delay, brachydactyly, and subcutaneous calcifications (suggesting Albright hereditary osteodystrophy), plus hypocalcemia, hyperphosphatemia, elevated PTH, and seizures (indicating PTH resistance in pseudohypoparathyroidism type 1A, PHP1A). These findings point to GNAS imprinting defects, making methylation-specific PCR (B) the most appropriate test to confirm abnormal methylation patterns, distinguishing PHP1A from other forms. No main logical issues; the stem provides sufficient discriminating details for a single best answer without contradictions or underspecification. No main medical accuracy issues; the item's logic aligns with current standards for PHP1A diagnosis, emphasizing methylation analysis over standard sequencing due to imprinting involvement, consistent with endocrine guidelines and board-level knowledge. Minimal fix: None needed, as the item is unambiguous and accurate; however, to enhance clarity, option A could specify 'inactivating' instead of 'activating' mutations to better highlight the distractor's error.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-012", "question": "A 4-year-old boy with newly diagnosed high-risk T-cell ALL develops tumor lysis syndrome with uric acid 12 mg/dL and creatinine 2.5 mg/dL. He is found to have G6PD deficiency. Which of the following is the most appropriate management?", "options": ["Administer rasburicase 0.2 mg/kg IV daily", "Initiate aggressive hydration and allopurinol, avoid rasburicase", "Perform emergent hemodialysis", "Administer rasburicase 0.1 mg/kg with concurrent blood transfusion", "Initiate alkalinization of urine to pH >7.5"], "answer": "B", "answer_index": 1, "explanation": "Rasburicase is contraindicated in G6PD deficiency as it can precipitate severe hemolysis by generating hydrogen peroxide. In G6PD-deficient patients with tumor lysis syndrome, aggressive hydration and allopurinol are the mainstays of therapy. Hemodialysis is reserved for refractory cases. Alkalinization is no longer routinely recommended due to risk of calcium phosphate precipitation. The risk of hemolysis outweighs the benefits of rasburicase in this population.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 4-year-old with high-risk T-cell ALL, tumor lysis syndrome (TLS) featuring uric acid 12 mg/dL and creatinine 2.5 mg/dL, and G6PD deficiency. These clues emphasize the need for TLS management avoiding rasburicase due to hemolysis risk in G6PD deficiency, prioritizing hydration and allopurinol. The clinical problem asks for the most appropriate management of TLS in this context. Key discriminating findings: Elevated uric acid and creatinine indicating TLS, G6PD deficiency contraindicating rasburicase. Most likely next step: Aggressive hydration and allopurinol while avoiding rasburicase. Keyed answer B fits perfectly as it directly addresses the contraindication without requiring assumptions. Alternatives: A is incorrect due to rasburicase contraindication; C is premature as not refractory; D still uses rasburicase, risking hemolysis despite transfusion; E uses outdated alkalinization risking precipitation. No main logical issues; stem allows clear discrimination of B as unique best. No main medical accuracy issues; aligns with current guidelines (e.g., ASCO) contraindicating rasburicase in G6PD and de-emphasizing alkalinization. Minimal fix: None required, as item is already unambiguous and accurate; optionally, add 'refractory' to C for clarity.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 4-year-old with high-risk T-cell ALL, tumor lysis syndrome (TLS) featuring uric acid 12 mg/dL and creatinine 2.5 mg/dL, and G6PD deficiency. These clues emphasize the need for TLS management avoiding rasburicase due to hemolysis risk in G6PD deficiency, prioritizing hydration and allopurinol. The clinical problem asks for the most appropriate management of TLS in this context. Key discriminating findings: Elevated uric acid and creatinine indicating TLS, G6PD deficiency contraindicating rasburicase. Most likely next step: Aggressive hydration and allopurinol while avoiding rasburicase. Keyed answer B fits perfectly as it directly addresses the contraindication without requiring assumptions. Alternatives: A is incorrect due to rasburicase contraindication; C is premature as not refractory; D still uses rasburicase, risking hemolysis despite transfusion; E uses outdated alkalinization risking precipitation. No main logical issues; stem allows clear discrimination of B as unique best. No main medical accuracy issues; aligns with current guidelines (e.g., ASCO) contraindicating rasburicase in G6PD and de-emphasizing alkalinization. Minimal fix: None required, as item is already unambiguous and accurate; optionally, add 'refractory' to C for clarity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-013", "question": "A 6-year-old boy has significant difficulties with social communication, including inappropriate responses in conversation and difficulty understanding non-literal language. He does not have restricted interests or repetitive behaviors. Which assessment tool is most appropriate to differentiate Social Communication Disorder from autism spectrum disorder?", "options": ["Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)", "Social Communication Questionnaire (SCQ)", "Children's Communication Checklist (CCC-2)", "Social Responsiveness Scale (SRS)", "Gilliam Autism Rating Scale (GARS)"], "answer": "C", "answer_index": 2, "explanation": "The Children's Communication Checklist-2 specifically evaluates pragmatic language skills and social communication deficits while distinguishing these from restricted/repetitive behaviors characteristic of autism. The ADOS-2 and SCQ are designed to identify autism, not to differentiate SCD from ASD. The SRS measures social impairment but doesn't assess the full diagnostic criteria distinction. GARS is a screening tool for autism, not a differential diagnostic instrument.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 6-year-old boy with social communication difficulties (inappropriate conversational responses, trouble with non-literal language) but explicitly no restricted interests or repetitive behaviors, asking for tool to differentiate Social Communication Disorder (SCD) from autism spectrum disorder (ASD). These clues point to a tool focusing on pragmatic language deficits without assessing restricted/repetitive behaviors (RRBs), as SCD requires social deficits sans RRBs per DSM-5, while ASD includes both. The keyed answer C (Children's Communication Checklist-2, CCC-2) fits by evaluating pragmatic skills and distinguishing SCD from ASD's RRBs. Alternatives: A (ADOS-2) is for full ASD diagnosis including RRBs; B (SCQ) screens for ASD broadly; D (SRS) measures social impairment but not diagnostic distinction; E (GARS) is an autism screening tool. No main logical issues; stem is consistent, supports unique best answer without contradictions or underspecification. No main medical accuracy issues; aligns with DSM-5 criteria for SCD vs ASD and standard uses of these tools in pediatric psychiatry, reflecting current guidelines. Minimal fix: No edit required as item is already unambiguous and accurate; optionally, add 'per DSM-5' to stem for explicit reinforcement.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 6-year-old boy with social communication difficulties (inappropriate conversational responses, trouble with non-literal language) but explicitly no restricted interests or repetitive behaviors, asking for tool to differentiate Social Communication Disorder (SCD) from autism spectrum disorder (ASD). These clues point to a tool focusing on pragmatic language deficits without assessing restricted/repetitive behaviors (RRBs), as SCD requires social deficits sans RRBs per DSM-5, while ASD includes both. The keyed answer C (Children's Communication Checklist-2, CCC-2) fits by evaluating pragmatic skills and distinguishing SCD from ASD's RRBs. Alternatives: A (ADOS-2) is for full ASD diagnosis including RRBs; B (SCQ) screens for ASD broadly; D (SRS) measures social impairment but not diagnostic distinction; E (GARS) is an autism screening tool. No main logical issues; stem is consistent, supports unique best answer without contradictions or underspecification. No main medical accuracy issues; aligns with DSM-5 criteria for SCD vs ASD and standard uses of these tools in pediatric psychiatry, reflecting current guidelines. Minimal fix: No edit required as item is already unambiguous and accurate; optionally, add 'per DSM-5' to stem for explicit reinforcement.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-014", "question": "A 3-year-old boy of Palestinian descent presents with chronic multifocal osteomyelitis, dyserythropoietic anemia, and neutrophilic dermatosis. Genetic testing reveals LPIN2 mutation (Majeed syndrome). Which NSAID is most effective for long-term management?", "options": ["Ibuprofen 10 mg/kg every 6 hours", "Naproxen 5 mg/kg twice daily", "Indomethacin 1-2 mg/kg/day in divided doses", "Celecoxib 50 mg twice daily", "Aspirin 10 mg/kg every 4 hours"], "answer": "C", "answer_index": 2, "explanation": "Majeed syndrome is an autoinflammatory disease characterized by chronic recurrent multifocal osteomyelitis. Indomethacin is the NSAID of choice due to its potent anti-inflammatory effects and superior efficacy in autoinflammatory bone diseases compared to other NSAIDs. The response to indomethacin can also serve as a diagnostic clue. Other NSAIDs are less effective, and aspirin should be avoided in children due to Reye syndrome risk. COX-2 inhibitors have limited data in this rare condition.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 3-year-old boy with Palestinian descent, chronic multifocal osteomyelitis, dyserythropoietic anemia, neutrophilic dermatosis, and confirmed LPIN2 mutation diagnosing Majeed syndrome, an autoinflammatory disorder; question seeks most effective NSAID for long-term management. These findings imply need for potent anti-inflammatory agent effective in autoinflammatory bone diseases like CRMO. Main logical issue(s): None; stem provides sufficient details for discrimination without contradictions or underspecification, supporting Indomethacin as uniquely best due to its established efficacy. Alternatives are inferior: Ibuprofen and Naproxen less potent for this condition; Celecoxib has limited data in rare pediatric autoinflammatory diseases; Aspirin contraindicated in children due to Reye syndrome risk. Main medical accuracy issue(s): Mostly accurate per current knowledge; Indomethacin is indeed preferred for Majeed syndrome's CRMO component based on case reports and autoinflammatory guidelines, though evidence is limited due to rarity; aspirin avoidance aligns with standard pediatric care; no major errors, but doses in options (e.g., Celecoxib 50 mg BID for 3-year-old) may not be weight-adjusted precisely, yet this doesn't undermine the teaching point. Minimal fix: Adjust Celecoxib dose to weight-based (e.g., 4-6 mg/kg/day) for realism, but item is already valid.\",\n  \"medical_accuracy_score\": 4,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 3-year-old boy with Palestinian descent, chronic multifocal osteomyelitis, dyserythropoietic anemia, neutrophilic dermatosis, and confirmed LPIN2 mutation diagnosing Majeed syndrome, an autoinflammatory disorder; question seeks most effective NSAID for long-term management. These findings imply need for potent anti-inflammatory agent effective in autoinflammatory bone diseases like CRMO. Main logical issue(s): None; stem provides sufficient details for discrimination without contradictions or underspecification, supporting Indomethacin as uniquely best due to its established efficacy. Alternatives are inferior: Ibuprofen and Naproxen less potent for this condition; Celecoxib has limited data in rare pediatric autoinflammatory diseases; Aspirin contraindicated in children due to Reye syndrome risk. Main medical accuracy issue(s): Mostly accurate per current knowledge; Indomethacin is indeed preferred for Majeed syndrome's CRMO component based on case reports and autoinflammatory guidelines, though evidence is limited due to rarity; aspirin avoidance aligns with standard pediatric care; no major errors, but doses in options (e.g., Celecoxib 50 mg BID for 3-year-old) may not be weight-adjusted precisely, yet this doesn't undermine the teaching point. Minimal fix: Adjust Celecoxib dose to weight-based (e.g., 4-6 mg/kg/day) for realism, but item is already valid.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-015", "question": "A 2-year-old toddler ingests a 0.3 mg clonidine transdermal patch. Six hours later, he becomes lethargic with bradycardia (HR 60) and hypotension (BP 70/40). Which of the following is the most appropriate management?", "options": ["Administer activated charcoal and observe", "Initiate atropine 0.02 mg/kg IV for bradycardia", "Administer naloxone 0.1 mg/kg IV bolus followed by continuous infusion", "Initiate dopamine infusion at 5 mcg/kg/min", "Perform gastric lavage and administer whole bowel irrigation"], "answer": "C", "answer_index": 2, "explanation": "Clonidine toxicity causes central alpha-2 agonist-mediated CNS depression and sympathetic outflow inhibition. Naloxone competitively displaces clonidine from opioid receptors, reversing both respiratory depression and hemodynamic instability. A continuous infusion is often required due to clonidine's long half-life. Atropine may not effectively counteract the central mechanism of bradycardia. Activated charcoal is ineffective after 6 hours, and dopamine treats symptoms but not the underlying toxicity.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: Ingestion of 0.3 mg clonidine transdermal patch by a 2-year-old, presenting 6 hours later with lethargy (CNS depression), bradycardia (HR 60), and hypotension (BP 70/40), pointing to clonidine toxicity via central alpha-2 agonism; these symptoms support naloxone as a targeted intervention for reversal in pediatric cases.\\nMain logical issue(s), if any: None; the stem provides sufficient details to discriminate C as the single best option, with alternatives less specific or untimely.\\nMain medical accuracy issue(s), if any: The item's keyed answer aligns with mainstream toxicology guidelines (e.g., trial of naloxone for altered mental status in clonidine overdose, per UpToDate and AAPCC); however, the provided rationale inaccurately states naloxone 'competitively displaces clonidine from opioid receptors'—clonidine is not an opioid agonist, and the mechanism of naloxone's benefit is unclear but empirical, possibly involving endogenous opioids.\\nMinimal fix: Revise the rationale to state: 'Naloxone may empirically reverse CNS depression and hemodynamic effects in pediatric clonidine overdose, though the exact mechanism is unknown; infusion is used due to clonidine's long half-life.'\",\n  \"medical_accuracy_score\": 3,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: Ingestion of 0.3 mg clonidine transdermal patch by a 2-year-old, presenting 6 hours later with lethargy (CNS depression), bradycardia (HR 60), and hypotension (BP 70/40), pointing to clonidine toxicity via central alpha-2 agonism; these symptoms support naloxone as a targeted intervention for reversal in pediatric cases.\nMain logical issue(s), if any: None; the stem provides sufficient details to discriminate C as the single best option, with alternatives less specific or untimely.\nMain medical accuracy issue(s), if any: The item's keyed answer aligns with mainstream toxicology guidelines (e.g., trial of naloxone for altered mental status in clonidine overdose, per UpToDate and AAPCC); however, the provided rationale inaccurately states naloxone 'competitively displaces clonidine from opioid receptors'—clonidine is not an opioid agonist, and the mechanism of naloxone's benefit is unclear but empirical, possibly involving endogenous opioids.\nMinimal fix: Revise the rationale to state: 'Naloxone may empirically reverse CNS depression and hemodynamic effects in pediatric clonidine overdose, though the exact mechanism is unknown; infusion is used due to clonidine's long half-life.'", "medical_accuracy_score": 3, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-016", "question": "A 6-year-old girl with Freeman-Sheldon syndrome (whistling face syndrome) requires anesthesia for tendon release surgery. She has microstomia, micrognathia, and a short neck. Which airway management strategy is most appropriate?", "options": ["Awake fiberoptic intubation with nasal approach", "Inhalational induction with sevoflurane followed by video laryngoscopy", "Intravenous induction with propofol and direct laryngoscopy", "Use of laryngeal mask airway without intubation", "Perform tracheostomy under local anesthesia before surgery"], "answer": "A", "answer_index": 0, "explanation": "Freeman-Sheldon syndrome is associated with severe facial contractures, microstomia, and limited neck extension, making mask ventilation and intubation extremely difficult. Awake fiberoptic intubation is the gold standard to secure the airway before induction of anesthesia. Inhalational induction risks airway obstruction in a patient who cannot be bag-mask ventilated effectively. Direct laryngoscopy is likely to fail due to limited mouth opening and neck mobility. LMA placement is challenging due to facial contractures.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The clinical problem asks for the most appropriate airway management strategy in a 6-year-old with Freeman-Sheldon syndrome featuring microstomia, micrognathia, and short neck, indicating a high-risk difficult airway for mask ventilation and intubation during tendon release surgery. Key stem clues driving a unique best answer include the syndrome's association with severe facial contractures and limited neck mobility, implying inability to effectively bag-mask ventilate or perform standard intubation. These support awake fiberoptic intubation (A) as it secures the airway before induction, minimizing risks of obstruction or 'can't intubate, can't ventilate' scenarios. No main logical issues; the stem provides sufficient details for discrimination without contradictions or underspecification, allowing a single defensible best answer. No main medical accuracy issues; this aligns with current anesthesia guidelines (e.g., ASA difficult airway algorithm) emphasizing awake techniques for anticipated difficult pediatric airways where ventilation is doubtful, though pediatric cooperation for awake fiberoptic requires expertise. Alternatives are inferior: B risks airway loss during inhalational induction; C exacerbates issues with muscle relaxation; D faces placement challenges due to microstomia; E is overly invasive without indication. Minimal fix: None necessary, as the item is already unambiguous and accurate; optionally, add 'with topical anesthesia and sedation' to option A for enhanced realism.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The clinical problem asks for the most appropriate airway management strategy in a 6-year-old with Freeman-Sheldon syndrome featuring microstomia, micrognathia, and short neck, indicating a high-risk difficult airway for mask ventilation and intubation during tendon release surgery. Key stem clues driving a unique best answer include the syndrome's association with severe facial contractures and limited neck mobility, implying inability to effectively bag-mask ventilate or perform standard intubation. These support awake fiberoptic intubation (A) as it secures the airway before induction, minimizing risks of obstruction or 'can't intubate, can't ventilate' scenarios. No main logical issues; the stem provides sufficient details for discrimination without contradictions or underspecification, allowing a single defensible best answer. No main medical accuracy issues; this aligns with current anesthesia guidelines (e.g., ASA difficult airway algorithm) emphasizing awake techniques for anticipated difficult pediatric airways where ventilation is doubtful, though pediatric cooperation for awake fiberoptic requires expertise. Alternatives are inferior: B risks airway loss during inhalational induction; C exacerbates issues with muscle relaxation; D faces placement challenges due to microstomia; E is overly invasive without indication. Minimal fix: None necessary, as the item is already unambiguous and accurate; optionally, add 'with topical anesthesia and sedation' to option A for enhanced realism.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-017", "question": "A 45-year-old woman on methadone 120 mg daily for chronic pain develops torsades de pointes with QTc 580 ms. She is hemodynamically unstable. Which medication is most appropriate for acute management?", "options": ["Amiodarone 150 mg IV bolus", "Magnesium sulfate 2 g IV bolus", "Isoproterenol infusion", "Lidocaine 1 mg/kg IV bolus", "Procainamide 15 mg/kg IV infusion"], "answer": "C", "answer_index": 2, "explanation": "Torsades de pointes in acquired long QT syndrome is a pause-dependent arrhythmia. Isoproterenol increases heart rate, shortening the QT interval and preventing the short-long RR interval sequence that precipitates TdP. While magnesium is first-line for stable TdP, isoproterenol is preferred in hemodynamically unstable patients. Amiodarone and procainamide further prolong the QT interval and are contraindicated. Lidocaine is ineffective for TdP.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. The clinical problem asks for the most appropriate medication for acute management of hemodynamically unstable torsades de pointes (TdP) in a 45-year-old woman with methadone-induced QT prolongation (QTc 580 ms). Key stem clues: methadone 120 mg daily (QT-prolonging), TdP, hemodynamic instability; absent details on heart rate, bradycardia, pauses, or recurrence. These drive toward standard TdP management but fail to specify factors favoring isoproterenol over magnesium. Most likely diagnosis: acquired long QT syndrome causing TdP. Keyed answer C (isoproterenol infusion) fits if assuming pause-dependent bradycardia to increase HR and prevent triggers, but requires unstated assumption. Alternatives: A (amiodarone) and E (procainamide) worsen QT prolongation, contraindicated; D (lidocaine) ineffective for TdP; B (magnesium sulfate) is standard first-line pharmacologic suppression per AHA/UpToDate guidelines, even in unstable patients post-cardioversion. Main logical issue: Unique best answer exists (B), but key mismatches it (K). Main medical accuracy issues: Rationale inaccurately claims magnesium for stable TdP only and isoproterenol preferred for unstable; guidelines recommend magnesium universally for acute TdP, isoproterenol for recurrent bradycardia-associated cases. Minimal fix: Change key to B and update rationale to reflect standard guidelines.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. The clinical problem asks for the most appropriate medication for acute management of hemodynamically unstable torsades de pointes (TdP) in a 45-year-old woman with methadone-induced QT prolongation (QTc 580 ms). Key stem clues: methadone 120 mg daily (QT-prolonging), TdP, hemodynamic instability; absent details on heart rate, bradycardia, pauses, or recurrence. These drive toward standard TdP management but fail to specify factors favoring isoproterenol over magnesium. Most likely diagnosis: acquired long QT syndrome causing TdP. Keyed answer C (isoproterenol infusion) fits if assuming pause-dependent bradycardia to increase HR and prevent triggers, but requires unstated assumption. Alternatives: A (amiodarone) and E (procainamide) worsen QT prolongation, contraindicated; D (lidocaine) ineffective for TdP; B (magnesium sulfate) is standard first-line pharmacologic suppression per AHA/UpToDate guidelines, even in unstable patients post-cardioversion. Main logical issue: Unique best answer exists (B), but key mismatches it (K). Main medical accuracy issues: Rationale inaccurately claims magnesium for stable TdP only and isoproterenol preferred for unstable; guidelines recommend magnesium universally for acute TdP, isoproterenol for recurrent bradycardia-associated cases. Minimal fix: Change key to B and update rationale to reflect standard guidelines.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-018", "question": "A mother is undergoing forensic psychiatric evaluation for allegedly causing medical illness in her child (factitious disorder imposed on another). She denies any intentional behavior. Which assessment tool is specifically designed to detect malingering and factitious behavior in forensic settings?", "options": ["Minnesota Multiphasic Personality Inventory-2 (MMPI-2)", "Structured Interview of Reported Symptoms (SIRS)", "Miller Forensic Assessment of Symptoms Test (M-FAST)", "Personality Assessment Inventory (PAI)", "Hare Psychopathy Checklist-Revised (PCL-R)"], "answer": "C", "answer_index": 2, "explanation": "The M-FAST is a brief screening tool specifically designed to assess malingering and symptom exaggeration in forensic evaluations. It has validated cut-off scores for detecting factitious presentations. While the MMPI-2 and PAI have validity scales, they are not as specific for factitious disorders. The SIRS assesses malingered psychosis, not factitious behavior. The PCL-R assesses psychopathy traits, not symptom validity.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include a forensic psychiatric evaluation for alleged factitious disorder imposed on another (e.g., causing medical illness in child), with denial of intentional behavior, and the need for a tool specifically detecting malingering and factitious behavior in forensic settings. These clues point to a specialized screening instrument for symptom exaggeration or fabrication in legal contexts, uniquely supporting M-FAST as the best fit due to its design for rapid assessment of malingered psychiatric symptoms with validated cutoffs for factitious presentations. No main logical issues; the stem is coherent, options are discriminable, and exactly one best answer emerges without unstated assumptions. No main medical accuracy issues; the item's logic aligns with current psychiatric standards, where M-FAST is recognized for forensic malingering detection, including factitious behaviors, per guidelines like those from the American Psychological Association. Alternatives are appropriately inferior: MMPI-2 and PAI offer general validity scales but lack specificity; SIRS targets malingered psychosis, not factitious; PCL-R assesses psychopathy, irrelevant here. Minimal fix: None needed, as the item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include a forensic psychiatric evaluation for alleged factitious disorder imposed on another (e.g., causing medical illness in child), with denial of intentional behavior, and the need for a tool specifically detecting malingering and factitious behavior in forensic settings. These clues point to a specialized screening instrument for symptom exaggeration or fabrication in legal contexts, uniquely supporting M-FAST as the best fit due to its design for rapid assessment of malingered psychiatric symptoms with validated cutoffs for factitious presentations. No main logical issues; the stem is coherent, options are discriminable, and exactly one best answer emerges without unstated assumptions. No main medical accuracy issues; the item's logic aligns with current psychiatric standards, where M-FAST is recognized for forensic malingering detection, including factitious behaviors, per guidelines like those from the American Psychological Association. Alternatives are appropriately inferior: MMPI-2 and PAI offer general validity scales but lack specificity; SIRS targets malingered psychosis, not factitious; PCL-R assesses psychopathy, irrelevant here. Minimal fix: None needed, as the item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-019", "question": "A 35-year-old man with treatment-resistant schizophrenia on clozapine 500 mg daily develops severe nocturnal sialorrhea with recurrent aspiration pneumonia. Which medication is most effective for this side effect?", "options": ["Benztropine 2 mg at bedtime", "Atropine ophthalmic solution 1% administered sublingually at bedtime", "Amantadine 100 mg twice daily", "Glycopyrrolate 1 mg twice daily", "Ipratropium bromide nasal spray"], "answer": "B", "answer_index": 1, "explanation": "Clozapine-induced sialorrhea is mediated by muscarinic M3 receptor agonism. Sublingual atropine ophthalmic solution provides potent anticholinergic effects locally, reducing salivation without significant systemic side effects. Glycopyrrolate and benztropine have poor CNS penetration and are less effective for nocturnal sialorrhea. Amantadine is ineffective for this side effect. Ipratropium nasal spray has minimal effect on salivation.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 35-year-old man with treatment-resistant schizophrenia on clozapine 500 mg daily, severe nocturnal sialorrhea leading to recurrent aspiration pneumonia; question seeks most effective medication for this side effect. These clues point to clozapine-induced hypersalivation, often managed with targeted anticholinergics to minimize systemic effects, especially nocturnally. The keyed answer B (sublingual atropine) fits due to its potent local muscarinic antagonism reducing salivation with low systemic absorption, addressing nocturnal severity and aspiration risk. Alternatives: A (benztropine) has limited efficacy for sialorrhea due to poor specificity and CNS penetration; C (amantadine) targets extrapyramidal symptoms, not salivation; D (glycopyrrolate) is systemic anticholinergic but less effective nocturnally with potential side effects; E (ipratropium nasal spray) acts on nasal secretions, ineffective for oral salivation. Main logical issue(s): None; stem provides sufficient details for discriminating B as uniquely best without contradictions or underspecification. Main medical accuracy issue(s): None; aligns with current psychiatric guidelines (e.g., APA, Maudsley) recommending sublingual atropine for clozapine sialorrhea as first-line due to efficacy and safety profile; rationale's explanation of M3 agonism is accurate. Minimal fix: None needed; item is unambiguous and accurate as is.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 35-year-old man with treatment-resistant schizophrenia on clozapine 500 mg daily, severe nocturnal sialorrhea leading to recurrent aspiration pneumonia; question seeks most effective medication for this side effect. These clues point to clozapine-induced hypersalivation, often managed with targeted anticholinergics to minimize systemic effects, especially nocturnally. The keyed answer B (sublingual atropine) fits due to its potent local muscarinic antagonism reducing salivation with low systemic absorption, addressing nocturnal severity and aspiration risk. Alternatives: A (benztropine) has limited efficacy for sialorrhea due to poor specificity and CNS penetration; C (amantadine) targets extrapyramidal symptoms, not salivation; D (glycopyrrolate) is systemic anticholinergic but less effective nocturnally with potential side effects; E (ipratropium nasal spray) acts on nasal secretions, ineffective for oral salivation. Main logical issue(s): None; stem provides sufficient details for discriminating B as uniquely best without contradictions or underspecification. Main medical accuracy issue(s): None; aligns with current psychiatric guidelines (e.g., APA, Maudsley) recommending sublingual atropine for clozapine sialorrhea as first-line due to efficacy and safety profile; rationale's explanation of M3 agonism is accurate. Minimal fix: None needed; item is unambiguous and accurate as is.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-020", "question": "A 40-year-old Puerto Rican woman presents to the emergency department with acute episode of screaming, crying, trembling, and feeling detached from her body after receiving news of her mother's death. Family reports this is an 'ataque de nervios.' Which of the following is the most appropriate DSM-5 diagnosis?", "options": ["Panic disorder, with cultural idiom", "Dissociative identity disorder", "Acute stress disorder", "Other specified trauma- and stressor-related disorder (ataque de nervios)", "No psychiatric diagnosis; this is a culturally normative expression of grief"], "answer": "D", "answer_index": 3, "explanation": "'Ataque de nervios' is recognized in DSM-5 as a cultural syndrome that can be classified under 'Other specified trauma- and stressor-related disorder' when symptoms cause clinically significant distress. It is not considered a normative expression of grief when it results in functional impairment. While it shares features with panic and dissociative disorders, the specific cultural framework warrants its own diagnostic category. Acute stress disorder requires more persistent symptoms beyond the acute episode.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include the patient's Puerto Rican background, acute symptoms of screaming, crying, trembling, and detachment following her mother's death, and the family's identification of 'ataque de nervios' as a cultural idiom. These elements align precisely with DSM-5's recognition of ataque de nervios as a syndrome involving emotional distress triggered by stressors, warranting classification under 'Other specified trauma- and stressor-related disorder' when causing significant distress. Main logical issue(s): None; the vignette provides sufficient details to discriminate options without contradictions or underspecification, supporting D as the unique best choice. Main medical accuracy issue(s): None; the item accurately reflects DSM-5 cultural syndromes and diagnostic criteria, consistent with current psychiatric standards. It distinguishes ataque de nervios from panic (A, lacks cultural specificity), dissociative identity disorder (B, no identity alteration), acute stress disorder (C, requires persistent re-experiencing and avoidance beyond acute episode), and normative grief (E, symptoms indicate clinical distress). Minimal fix: None required, as the item is already unambiguous and accurate. The clinical problem asks for the most appropriate DSM-5 diagnosis for a culturally framed acute distress episode. Discriminating findings: Positive (cultural label, acute post-loss symptoms); negative (no mention of recurrent panic, multiple identities, or prolonged trauma symptoms). Implied diagnosis: Ataque de nervios under specified category. Keyed answer fits without assumptions. Alternatives are inferior due to mismatch with cultural framework or symptom duration.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include the patient's Puerto Rican background, acute symptoms of screaming, crying, trembling, and detachment following her mother's death, and the family's identification of 'ataque de nervios' as a cultural idiom. These elements align precisely with DSM-5's recognition of ataque de nervios as a syndrome involving emotional distress triggered by stressors, warranting classification under 'Other specified trauma- and stressor-related disorder' when causing significant distress. Main logical issue(s): None; the vignette provides sufficient details to discriminate options without contradictions or underspecification, supporting D as the unique best choice. Main medical accuracy issue(s): None; the item accurately reflects DSM-5 cultural syndromes and diagnostic criteria, consistent with current psychiatric standards. It distinguishes ataque de nervios from panic (A, lacks cultural specificity), dissociative identity disorder (B, no identity alteration), acute stress disorder (C, requires persistent re-experiencing and avoidance beyond acute episode), and normative grief (E, symptoms indicate clinical distress). Minimal fix: None required, as the item is already unambiguous and accurate. The clinical problem asks for the most appropriate DSM-5 diagnosis for a culturally framed acute distress episode. Discriminating findings: Positive (cultural label, acute post-loss symptoms); negative (no mention of recurrent panic, multiple identities, or prolonged trauma symptoms). Implied diagnosis: Ataque de nervios under specified category. Keyed answer fits without assumptions. Alternatives are inferior due to mismatch with cultural framework or symptom duration.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]